The global Neurological Biomarkers market was valued at $XX million in 2018, and Global Research View analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Neurological Biomarkers from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Neurological Biomarkers market.

Leading players of Neurological Biomarkers including:
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz

Market split by Type, can be divided into:
Proteomics
Genomics
Imaging
Bioinformatics
Others

Market split by Application, can be divided into:
Diagnostics
Drug Discovery
Personalized Medicine
Others

Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel

Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America Brazil, Argentina, Colombia and Chile etc.)
Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

Table of Contents

Chapter 1 Neurological Biomarkers Market Overview
1.1 Neurological Biomarkers Definition
1.2 Global Neurological Biomarkers Market Size Status and Outlook (2021-2026)
1.3 Global Neurological Biomarkers Market Size Comparison by Region (2021-2026)
1.4 Global Neurological Biomarkers Market Size Comparison by Type (2021-2026)
1.5 Global Neurological Biomarkers Market Size Comparison by Application (2021-2026)
1.6 Global Neurological Biomarkers Market Size Comparison by Sales Channel (2021-2026)
1.7 Neurological Biomarkers Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Neurological Biomarkers Market Segment Analysis by Player
2.1 Global Neurological Biomarkers Sales and Market Share by Player (2016-2018)
2.2 Global Neurological Biomarkers Revenue and Market Share by Player (2016-2018)
2.3 Global Neurological Biomarkers Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Neurological Biomarkers Market Segment Analysis by Type
3.1 Global Neurological Biomarkers Market by Type
3.1.1 Proteomics
3.1.2 Genomics
3.1.3 Imaging
3.1.4 Bioinformatics
3.1.5 Others
3.2 Global Neurological Biomarkers Sales and Market Share by Type (2013-2018)
3.3 Global Neurological Biomarkers Revenue and Market Share by Type (2013-2018)
3.4 Global Neurological Biomarkers Average Price by Type (2013-2018)
3.5 Leading Players of Neurological Biomarkers by Type in 2018
3.6 Conclusion of Segment by Type
Chapter 4 Neurological Biomarkers Market Segment Analysis by Application
4.1 Global Neurological Biomarkers Market by Application
4.1.1 Diagnostics
4.1.2 Drug Discovery
4.1.3 Personalized Medicine
4.1.4 Others
4.2 Global Neurological Biomarkers Sales and Market Share by Application (2013-2018)
4.3 Leading Consumers of Neurological Biomarkers by Application in 2018
4.4 Conclusion of Segment by Application
Chapter 5 Neurological Biomarkers Market Segment Analysis by Sales Channel
5.1 Global Neurological Biomarkers Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Neurological Biomarkers Sales and Market Share by Sales Channel (2013-2018)
5.3 Leading Distributors/Dealers of Neurological Biomarkers by Sales Channel in 2018
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Neurological Biomarkers Market Segment Analysis by Region
6.1 Global Neurological Biomarkers Market Size and CAGR by Region (2021-2026)
6.2 Global Neurological Biomarkers Sales and Market Share by Region (2013-2018)
6.3 Global Neurological Biomarkers Revenue and Market Share by Region (2013-2018)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Neurological Biomarkers Market Share by Type
6.4.3 North America Neurological Biomarkers Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Neurological Biomarkers Market Share by Type
6.5.3 Europe Neurological Biomarkers Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Neurological Biomarkers Market Share by Type
6.6.3 Asia-Pacific Neurological Biomarkers Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Neurological Biomarkers Market Share by Type
6.7.3 South America Neurological Biomarkers Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.7.7 Chile
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Neurological Biomarkers Market Share by Type
6.8.3 Middle East & Africa Neurological Biomarkers Market Share by Application
6.8.4 Egypt
6.8.5 Saudi Arabia
6.8.6 South Africa
6.8.7 Nigeria
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Neurological Biomarkers Players
7.1 Merck
7.1.1 Company Snapshot
7.1.2 Product/Business Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 Strategy and SWOT Analysis
7.2 Quest Diagnostics
7.3 Abbott
7.4 Roche
7.5 Illumina
7.6 Bio-Rad Laboratories
7.7 QIAGEN
7.8 Myriad RBM
7.9 Cisbio Bioassays
7.10 Athena Diagnostics
7.11 BGI
7.12 Wuxi APP
7.13 Aepodia
7.14 Proteome Sciences
7.15 Genewiz
Chapter 8 Upstream and Downstream Analysis of Neurological Biomarkers
8.1 Industrial Chain of Neurological Biomarkers
8.2 Upstream of Neurological Biomarkers
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Neurological Biomarkers
8.3.1 Leading Distributors/Dealers of Neurological Biomarkers
8.3.2 Leading Consumers of Neurological Biomarkers
Chapter 9 Development Trend of Neurological Biomarkers (2019-2028)
9.1 Global Neurological Biomarkers Market Size (Sales and Revenue) Forecast (2019-2028)
9.2 Global Neurological Biomarkers Market Size and CAGR Forecast by Region (2019-2028)
9.3 Global Neurological Biomarkers Market Size and CAGR Forecast by Type (2019-2028)
9.4 Global Neurological Biomarkers Market Size and CAGR Forecast by Application (2019-2028)
9.5 Global Neurological Biomarkers Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

Share This Report

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Payment Mode

About This Report

Category
Report ID92520
CategoryPharma & Healthcare
Published on21-Jun
Publisher NameGlobal Research View

Why us

We are a dynamic team of industry researchers and provide efficient and effective solutions

with trusted and validated data points

  • We offer seamless support at pre and post-sales stage to guide our clients in crucial and strategic business decision plans
  • Innovative research techniques and approaches are implemented to offer key strategic insights
  • Our mission is to offer next to accurate information on fast evolving and dynamic market situations to boost capitalization and revenue acquisition
  • From SMEs to Fortune 500 companies we are the decision support system
  • Fewer assumptions and more precise analysis to foster accurate results
  • We completely believe in insights-driven and data-driven research approach
  • Highlighting forecast on investment feasibility, strategic mergers and acquisitions across       developed, developing and niche markets



REPORT CATEGORIES